SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Turnover for the quarter ended December 2024 of Rs. 22512.80 millions increase by 64.92% from Rs. 13650.96 millions.The Total Profit for the quarter ended December 2024 of Rs. 4138.03 millions grew from Rs.-204.09 millionsOperating profit surged to 6231.16 millions from the corresponding previous quarter of 745.47 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 22512.80 13650.96 64.92 72169.16 57428.96 25.67 78911.19 82206.62 -4.01
Other Income 1291.89 2588.15 -50.08 2679.14 3817.54 -29.82 11680.24 9859.39 18.47
PBIDT 6231.16 745.47 735.87 21715.69 11259.72 92.86 24096.87 24587.06 -1.99
Interest 84.62 736.04 -88.50 356.06 1937.25 -81.62 2771.10 2068.16 33.99
PBDT 6146.54 -243.40 -2625.28 21359.63 8556.66 149.63 72029.08 17560.22 310.18
Depreciation 551.64 511.62 7.82 1631.00 1497.60 8.91 2021.62 1841.48 9.78
PBT 5594.90 -755.02 -841.03 19728.63 7059.06 179.48 70007.46 15718.74 345.38
TAX 1456.87 -550.93 -364.44 5102.73 1523.05 235.03 18334.55 3631.05 404.94
Deferred Tax 504.26 -19.26 -2718.17 1685.65 1576.92 6.90 7834.63 -238.26 -3388.27
PAT 4138.03 -204.09 -2127.55 14625.90 5536.01 164.20 51672.91 12087.69 327.48
Equity 282.19 282.17 0.01 282.19 282.17 0.01 282.19 282.17 0.01
PBIDTM(%) 27.68 5.46 406.85 30.09 19.61 53.47 30.54 29.91 2.10

Glenmark Pharma Share Price

2364.35 -6.70 (-0.28%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×